Michael T. Andriole - Feb 14, 2024 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role: PRESIDENT AND CEO, Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Stock symbol: CMRX
Transactions as of: Feb 14, 2024
Transactions value $: -$1,809
Form type: 4
Date filed: 2/16/2024, 08:02 PM
Previous filing: Feb 2, 2024
Next filing: Aug 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Sale	-$1.81K	-1.74K	-0.39%	$1.04	447K	Feb 14, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit award granted on January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit award.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.03 to $1.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Content

The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit award granted on January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit award.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.03 to $1.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.